What is Claire-Audrey Bayan's NPI number?

Claire-Audrey Bayan's National Provider Identifier (NPI) is 1932767399, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Claire-Audrey Bayan's specialty?

Claire-Audrey Bayan is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Claire-Audrey Bayan located?

Claire-Audrey Bayan's practice location on file with NPPES is 9555 Upland Ln N, Maple Grove, MN 55369-4485.

What is Claire-Audrey Bayan's phone number?

The practice phone number listed in the NPPES registry for Claire-Audrey Bayan is (952) 993-1440.

Does Claire-Audrey Bayan accept Medicare?

Claire-Audrey Bayan is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Claire-Audrey Bayan's NPI active?

Yes — Claire-Audrey Bayan's NPI (1932767399) is active in the NPPES registry as of the last update on 2026-02-20.

IndividualActiveAccepts Medicare

Claire-Audrey Bayan, MD

NPI 1932767399 · Dermatology Physician · Maple Grove, MN

Claire-Audrey Bayan, MD is a Dermatology Physician provider in Maple Grove, MN (NPI 1932767399).

Provider details

NPI number: 1932767399
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: MD
Sex: Female
Sole proprietor: Yes
License: 81458 (MN)

Practice location

9555 Upland Ln N

Maple Grove, MN 55369-4485

Phone: (952) 993-1440

Street-level locationGet directions

More MN providers

Mailing address

8170 33rd Ave S

Bloomington, MN 55425-4516

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense 81458 (MN)
Allopathic & Osteopathic Physicians
Dermatology Physician207N00000XLicense A196309 (CA)
Allopathic & Osteopathic Physicians

Additional practice locations (1)

2320 Woolsey St Ste 202
Berkeley, CA 94705-1975
Phone: (510) 486-1700

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(59/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
7 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
2 documented practice locations
Medicare service volume (vs. specialty peers)25% of score
785 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	309	$9
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	98	$154
Destruction of Precancer Skin Growth, 1 Growth17000	95	$72
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	78	$110
Biopsy of Related Skin Growth, First Growth11102	46	$123
Destruction of Skin Growth, 1-14 Growths

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 5 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	45	34
Triamcinolone Acetonide	40	34
Mupirocin	29	25
Hydrocortisone	15	14
Fluorouracil	13	13

Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do not include cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means no Part D record, never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$562 across 19 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2019-05-31
Last updated: 2026-02-20
Certified: 2026-02-20

Frequently asked questions

What is Claire-Audrey Bayan's NPI number?: Claire-Audrey Bayan's National Provider Identifier (NPI) is 1932767399, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Claire-Audrey Bayan's specialty?: Claire-Audrey Bayan is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Claire-Audrey Bayan located?: Claire-Audrey Bayan's practice location on file with NPPES is 9555 Upland Ln N, Maple Grove, MN 55369-4485.
What is Claire-Audrey Bayan's phone number?: The practice phone number listed in the NPPES registry for Claire-Audrey Bayan is (952) 993-1440.
Does Claire-Audrey Bayan accept Medicare?: Claire-Audrey Bayan is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Claire-Audrey Bayan's NPI active?: Yes — Claire-Audrey Bayan's NPI (1932767399) is active in the NPPES registry as of the last update on 2026-02-20.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	309	$9
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	98	$154
Destruction of Precancer Skin Growth, 1 Growth17000	95	$72
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	78	$110
Biopsy of Related Skin Growth, First Growth11102	46	$123
Destruction of Skin Growth, 1-14 Growths

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 5 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	45	34
Triamcinolone Acetonide	40	34
Mupirocin	29	25
Hydrocortisone	15	14
Fluorouracil	13	13

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$562 across 19 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Additional practice locations (1)

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Additional practice locations (1)

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments